Celera Corporation Email Format

Biotechnology ResearchCalifornia, United States51-200 Employees

Celera Corporation operates in the biotechnology research sector, focusing on diagnostic testing to identify inherent disease risk and guide subsequent management. Its Products division creates molecular diagnostic tools to detect, characterize, monitor, and direct treatment for disease, while Berkeley HeartLab provides cardiovascular risk testing and related guidance to physicians. The 4myheart centers translate test results into personalized regimens for exercise, nutrition, stress management, and therapy adherence under physician supervision.

Based in Alameda, California, the company targets clinicians and patients seeking to understand disease risk and personalize care, aiming to improve outcomes and potentially reduce overall health costs. In May 2024, Celera announced a collaboration with Aura Astronomy to use AURA's OPUS software, illustrating ongoing development activity beyond its core diagnostics.

Sign up for free to view info

Company overview Employee directory